Home

purement Être surpris Comparable anita sveen Accessible Artefact Désarmement

CMScaller: an R package for consensus molecular subtyping of colorectal  cancer pre-clinical models – topic of research paper in Biological  sciences. Download scholarly article PDF and read for free on CyberLeninka  open
CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on CyberLeninka open

Multilevel genomics of colorectal cancers with microsatellite  instability—clinical impact of JAK1 mutations and consensus molecular  subtype 1 – topic of research paper in Clinical medicine. Download  scholarly article PDF and read for
Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1 – topic of research paper in Clinical medicine. Download scholarly article PDF and read for

Sammen blir det bedre
Sammen blir det bedre

OUH - OUS-research.no
OUH - OUS-research.no

132 Dr Anita Sveen - YouTube
132 Dr Anita Sveen - YouTube

OUH - Molecular Oncology
OUH - Molecular Oncology

Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical  Models Uncover Potentially Targetable Cancer Cell Dependencies | Clinical  Cancer Research
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies | Clinical Cancer Research

Dr Anita Sveen received the Young Investigator prize at Onkologisk Forum  for her research accomplishments - K.G. Jebsen Colorectal Cancer Research  Centre
Dr Anita Sveen received the Young Investigator prize at Onkologisk Forum for her research accomplishments - K.G. Jebsen Colorectal Cancer Research Centre

Anita SVEEN | Oslo University Hospital, Oslo
Anita SVEEN | Oslo University Hospital, Oslo

OUH - Molecular Oncology
OUH - Molecular Oncology

OUH - Institute for Cancer Research
OUH - Institute for Cancer Research

Stiftelse støtter norsk medisinsk forskning med 48 millioner - Tu.no
Stiftelse støtter norsk medisinsk forskning med 48 millioner - Tu.no

Anita SVEEN | Oslo University Hospital, Oslo
Anita SVEEN | Oslo University Hospital, Oslo

OUH - Molecular Oncology
OUH - Molecular Oncology

Anita SVEEN | Oslo University Hospital, Oslo
Anita SVEEN | Oslo University Hospital, Oslo

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine  stratification of colorectal cancer
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer

Oppland Arbeiderblad - Anita (38) fra Toten forsker på kreft. Nå har gruppa  hun leder fått åtte millioner til forskning på immunterapi
Oppland Arbeiderblad - Anita (38) fra Toten forsker på kreft. Nå har gruppa hun leder fått åtte millioner til forskning på immunterapi

Tumour-infiltrating CD8 + lymphocytes and colorectal cancer recurrence by  tumour and nodal stage | British Journal of Cancer
Tumour-infiltrating CD8 + lymphocytes and colorectal cancer recurrence by tumour and nodal stage | British Journal of Cancer

Preclinical drug screening identifies novel stratified treatment options  according to the consensus molecular subtypes of colorectal cancer - K.G.  Jebsen Colorectal Cancer Research Centre
Preclinical drug screening identifies novel stratified treatment options according to the consensus molecular subtypes of colorectal cancer - K.G. Jebsen Colorectal Cancer Research Centre

Gene expression profiles of CMS2-epithelial/canonical colorectal cancers  are largely driven by DNA copy number gains | Oncogene
Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains | Oncogene

Lesernes blinkskudd - Hamar Arbeiderblad
Lesernes blinkskudd - Hamar Arbeiderblad

Nasjonal Kreftsatsing Konferanse 2016 - 10.-11. mars - Anita Sveen - YouTube
Nasjonal Kreftsatsing Konferanse 2016 - 10.-11. mars - Anita Sveen - YouTube

Anita Sveen - Institutt for klinisk medisin
Anita Sveen - Institutt for klinisk medisin

Ny kunnskap om tarmkreft med spredning - Kreftforeningen
Ny kunnskap om tarmkreft med spredning - Kreftforeningen